Our Vice President Speaks To How Biosimilars Affect Your Employees, And Information On Chronic Illness Support
Recent changes regarding provincial drug plans have attracted the attention of our clients and elevated the importance of how employers and sponsors should adapt to these initiatives. In this regard, Benchmark would like to take this opportunity to present insights from our Vice President, Group Benefits, Marcelina Ayow. We are fortunate to have a professional of Marcelina’s experience …









